SMETS FARMA
ActiveSummary
SMETS FARMA has been active since 2010 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €297k and a net result of €60k. Equity is growing by ~30.8% per year across the filed fiscal years. Its solvency ranks better than 44% of 10359 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.8% (low).
Checked score
Score 2025
61
/ 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability61▼-2
Solvency57▲+3
Growth78=
Track record100
Bankruptcy probability, 12 months
0.8%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €18k at 30 days acceptable
Liquidity ample (current ratio 1.82 against 1.92 in 2024; short-term debt: 25.6% and cash: 2.7% of total assets), but 68.5% of the assets are financed with debt.
Credit check for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
31.5%
Return on assets
6.3%
Age of the figures
12 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 12-02-2026, 77 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
77 d early
2024
71 d early
2023
76 d early
2022
76 d early
2021
43 d early
2020
64 d early
2019
71 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-09-2026 and is due by 30-04-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today30-09-2026 close30-04-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Source amounts without an identifiable currency are assumed to be EUR.
Turnover
€0
Total assets
€944k▲ 5.0%
2024 · €899k
2018: €1.13M
2019: €1.03M
2020: €999k
2021: €969k
2022: €824k
2023: €891k
2024: €899k
2018 → 2025
Net result
€60k▼ 30.2%
2024 · €86k
2018: €40k
2019: €40k
2020: €35k
2021: €35k
2022: €61k
2023: €35k
2024: €86k
2018 → 2025
Working capital
€199k▲ 4.4%
2024 · €191k
2018: €-149k
2019: €-64k
2020: €-90k
2021: €-90k
2022: €-66k
2023: €135k
2024: €191k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€116k-€156k▲ 35.4%€192k▲ 22.6%€258k▲ 34.3%€297k▲ 15.5%
Operating result€87k-€110k▲ 27.0%€73k▼ 33.7%€143k▲ 95.3%€101k▼ 29.1%
Net result€35k-€61k▲ 72.1%€35k▼ 41.9%€86k▲ 142%€60k▼ 30.2%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 29% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €944k
Fixed assets
€503k ▲ 0.2%
Current assets
€441k ▲ 11.1%
Equity and liabilities €944k
Equity
€297k ▲ 15.5%
Debt
€647k ▲ 0.8%
Debt's share of the balance-sheet total falls from 71.3% to 68.5%. Equity and debt are higher.
Key figures and ratios
EBITDA
€122k▼
2024 · €164k
Cash flow
€81k▼
2024 · €107k
Current ratio
1.82▼
2024 · 1.92
Quick ratio
1.08▼
2024 · 1.14
Debt to equity
2.17▼
2024 · 2.49
ROE
20.1%▼
2024 · 33.3%
ROA
6.3%▼
2024 · 9.5%
Interest coverage
4.12▲
2024 · 3.92
Debt ≤ 1 year
€242k▲
2024 · €206k
Debt > 1 year
€404k▼
2024 · €435k
Income taxes
€21k▼
2024 · €30k
Staff costs
€96k▲
2024 · €84k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 52 lines
Balance sheet
Code20242025
Assets
Total assets20/58€899k€944k▲
Fixed assets21/28€502k€503k▲
Tangible fixed assets22/27€502k€503k▲
Land and buildings22€493k€497k▲
Plant, machinery and equipment23€9k€6k▼
Current assets29/58€397k€441k▲
Stocks and contracts in progress3€163k€180k▲
Stocks30/36€163k€180k▲
Amounts receivable within one year40/41€118k€156k▲
Trade receivables40€90k€94k▲
Other amounts receivable41€27k€63k▲
Current investments50/53€57k€54k▼
Cash at bank and in hand54/58€37k€26k▼
Deferred charges and accrued income490/1€22k€24k▲
Equity and liabilities
Total equity and liabilities10/49€899k€944k▲
Equity10/15€258k€297k▲
Contributions10/11€19k€19k=
Reserves13€239k€279k▲
Distributable reserves133€239k€279k▲
Amounts payable17/49€642k€647k▲
Amounts payable after more than one year17€435k€404k▼
Financial debts170/4€435k€404k▼
Amounts payable within one year42/48€206k€242k▲
Current portion of amounts payable after more than one year42€30k€31k▲
Trade debts44€139k€179k▲
Suppliers440/4€139k€179k▲
Taxes, remuneration and social security45€17k€12k▼
Taxes450/3€10k€560▼
Remuneration and social security454/9€7k€12k▲
Other amounts payable47/48€20k€20k=
Accrued charges and deferred income492/3€507€507=
Income statement
Code20242025
Remuneration, social security and pensions62€84k€96k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€21k€21k▼
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€3k-
Other operating charges640/8€6k€5k▼
Non-recurring operating charges66A-€8k
Gross operating margin9900€256k€231k▼
Operating profit (loss)9901€143k€101k▼
Financial income75/76B€15k€9k▼
Recurring financial income75€15k€9k▼
Financial charges65/66B€42k€30k▼
Recurring financial charges65€42k€30k▼
Profit (loss) for the period before taxes9903€116k€81k▼
Income taxes67/77€30k€21k▼
Profit (loss) for the period9904€86k€60k▼
Profit (loss) for the period to be appropriated9905€86k€60k▼
Appropriation of the result
Profit (loss) to be appropriated9906€86k€60k▼
Transfer to equity691/2€66k€40k▼
To other reserves6921€66k€40k▼
Profit to be distributed694/7€20k€20k=
Return on contributions (dividend)694€20k€20k=
Social balance
Average headcount (FTE)90871.41.5▲
The notes to these accounts (12 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
12-02
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
18-02
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
30-09
Financial
Highest result since 2018net €86k ▲142%
Operating result €143k, net result €86k, both a record.
30-09
Financial
Equity above €200kEq €258k ▲34.3%
7 profitable years in a row build equity to €258k.
14-02
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
13-02
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
30-09
Financial
Equity above €150kEq €156k ▲35.4%
5 profitable years in a row build equity to €156k.
18-03
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
25-02
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
30-09
Financial
Weakest financial yearnet €35k ▼11.4%
Net result drops to €35k, the lowest in the series; recovery starts the following year.
30-09
Financial
Equity above €100kEq €100k ▲54.1%
3 profitable years in a row build equity to €100k.
19-02
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
Show earlier events
2019
27-02
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
06-03
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
28-02
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Antwerpen · 2 establishment units since 2010
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Letterkundestraat 22610 AntwerpenGround area
233 m²
Building footprint
162 m²
Volume, LiDAR
1,289 m³
2 parcels, Flanders · tallest building 10.6 m, ±3 floors. Linked by address, not a title deed.
2 establishment units
Smets Farma
since 20102.230.203.412
Letterkundestraat 4, 2610 Antwerpen
since 20222.329.980.184
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11462A0042/00V004 | Flanders | 153 m² | 1 · 107 m² | 10.6 m · 3 fl. |
| 11462A0042/00W004 | Flanders | 80 m² | 1 · 55 m² | 10.4 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Public money · subsidies and aid
Flemish government
2023 · 1 entry · 96 EUR awarded · 96 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2023 | 1 | 96 EUR | 96 EUR |
Schemes
Subsidie voor opleiding en advies voor kmo's en zelfstandigen (kmo-portefeuille)
Similar companies · same sector, comparable size
Apotheek Heulepark
BE 0699.794.622
Kortrijk · Eq €297,528
Pharmacie de Ittre
BE 0445.922.955
Ittre · Eq €297,344
APOTHEEK VREYS
BE 0430.832.428
Geel · Eq €297,757
PHARMACIE DU PETIT CHAMP
BE 0563.644.432
Pont-à-Celles · Eq €297,212
Apotheek Kalmthout Veraart
BE 0462.061.676
Kalmthout · Eq €297,001
Of 5,220 companies in sector 47730 we hold annual accounts for 3,861. 3,500 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded01-12-2010
Fiscal year end30-09
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
Sources
Crossroads Bank for EnterprisesNational Bank · 15 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.